journavx pain management

FDA approves non-opioid pain medication

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

USA TODAY on MSN · 3d

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Seeking Alpha · 2d

Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and why it is a Buy.

Experts: Journavx a prescription to stem Long Island's addiction crisis

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Sierra Sun Times1d

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New Approaches for Pain Management

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...

StudyFinds on MSN1d

Journavx: What to know about new FDA-approved non-opioid pain medication

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Psychology Today3d

Treating Pain—Avoiding the Brain

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results